Assembly Biosciences, Inc.

Historical 13F Holders

Symbol
ASMB
CUSIP
045396207
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 045396207 since 12/18/2024, newest first.

Filer % of Class Filed
Paradigm Biocapital Advisors LP 13G/A Amendment 1
7.8% 8/14/2026
Event 6/30/2026
Janus Henderson Group Ltd. 13G/A Amendment 1 6.9% 8/13/2026
Event 6/30/2026
Farallon Capital Management, L.L.C. 13G/A Amendment 2
8.1% 8/4/2026
Event 6/30/2026
Paradigm Biocapital Advisors LP 13G
5.4% 5/11/2026
Event 5/4/2026
Farallon Capital Partners, L.P. 13G/A Amendment 1
7.8% 2/9/2026
Event 12/31/2025
Janus Henderson Group PLC 13G 8.2% 12/8/2025
Event 11/28/2025
RA Capital Management, L.P. 13G
9.5% 8/18/2025
Event 8/11/2025
Alexander Schornstein 13G/A Amendment 3 3.5% 8/18/2025
Event 8/11/2025
Commodore Capital LP 13G
9.9% 8/15/2025
Event 8/8/2025
Farallon Capital Partners, L.P. 13G
7.3% 8/15/2025
Event 8/8/2025
Armistice Capital, LLC 13G/A Amendment 3
10.0% 8/14/2025
Event 6/30/2025
Alexander Schornstein 13G 4.7% 8/12/2025
Event 8/11/2025
Armistice Capital, LLC 13G/A Amendment 1
4.99% 2/14/2025
Event 12/31/2024
Alexander Schornstein 13G/A Amendment 1 10.0% 12/23/2024
Event 12/19/2024
Alexander Schornstein 13G 10.0% 12/23/2024
Event 6/24/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 20.0 $470.00
2026 Q2 96 18.8 M $515 M
2026 Q1 76 13.8 M $382 M
2025 Q4 69 13.7 M $467 M
2025 Q3 60 12.5 M $325 M
2025 Q2 35 3.15 M $57.1 M
2025 Q1 38 3.18 M $30.4 M
2024 Q4 36 3.19 M $50.3 M
2024 Q3 32 1.03 M $15.6 M
2024 Q2 31 1.18 M $16.1 M
2024 Q1 28 652 k $8.68 M